Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 59476 - 59500 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Piroxicam	Approved Investigational	SARS	6301	downregulated	Piroxicam results in decreased expression of SARS mRNA	1p13.3	A23661
Piroxicam	Approved Investigational	SCD	6319	downregulated	Piroxicam results in decreased expression of SCD mRNA	10q24.31	A23661
Piroxicam	Approved Investigational	SEL1L	6400	downregulated	Piroxicam results in decreased expression of SEL1L mRNA	14q31	A23661
Piroxicam	Approved Investigational	SELENOW	6415	downregulated	Piroxicam results in decreased expression of SELENOW mRNA	19q13.33	A23661
Piroxicam	Approved Investigational	SF3A3	10946	downregulated	Piroxicam results in decreased expression of SF3A3 mRNA	1p34.3	A23661
Piroxicam	Approved Investigational	SH2B3	10019	upregulated	Piroxicam results in increased expression of SH2B3 mRNA	12q24.12	A23661
Piroxicam	Approved Investigational	SH3GLB1	51100	downregulated	Piroxicam results in decreased expression of SH3GLB1 mRNA	1p22.3	A23661
Piroxicam	Approved Investigational	SHCBP1	79801	upregulated	Piroxicam results in increased expression of SHCBP1 mRNA	16q11.2	A23661
Piroxicam	Approved Investigational	SIVA1	10572	downregulated	Piroxicam results in decreased expression of SIVA1 mRNA	14q32.33	A23661
Piroxicam	Approved Investigational	SKP2	6502	downregulated	Piroxicam results in decreased expression of SKP2 mRNA	5p13.2	A23661
Piroxicam	Approved Investigational	SLC16A1	6566	upregulated	Piroxicam results in increased expression of SLC16A1 mRNA	1p13.2	A23661
Piroxicam	Approved Investigational	SLC25A12	8604	downregulated	Piroxicam results in decreased expression of SLC25A12 mRNA	2q31.1	A23661
Piroxicam	Approved Investigational	SLC25A13	10165	upregulated	Piroxicam results in increased expression of SLC25A13 mRNA	7q21.3	A23661
Piroxicam	Approved Investigational	SLC3A2	6520	downregulated	Piroxicam results in decreased expression of SLC3A2 mRNA	11q12.3	A23661
Piroxicam	Approved Investigational	SLC5A3	6526	upregulated	Piroxicam results in increased expression of SLC5A3 mRNA	21q22.11	A23661
Piroxicam	Approved Investigational	SLC6A15	55117	downregulated	Piroxicam results in decreased expression of SLC6A15 mRNA	12q21.31	A23661
Piroxicam	Approved Investigational	SLC7A11	23657	downregulated	Piroxicam results in decreased expression of SLC7A11 mRNA	4q28.3	A21015
Piroxicam	Approved Investigational	SLC7A5	8140	downregulated	Piroxicam results in decreased expression of SLC7A5 mRNA	16q24.2	A23661
Piroxicam	Approved Investigational	SLC7A8	23428	upregulated	Piroxicam results in increased expression of SLC7A8 mRNA	14q11.2	A21015
Piroxicam	Approved Investigational	SMARCA5	8467	downregulated	Piroxicam results in decreased expression of SMARCA5 mRNA	4q31.21	A23661
Piroxicam	Approved Investigational	SMARCE1	6605	downregulated	Piroxicam results in decreased expression of SMARCE1 mRNA	17q21.2	A23661
Piroxicam	Approved Investigational	SMC2	10592	downregulated	Piroxicam results in decreased expression of SMC2 mRNA	9q31.1	A23661
Piroxicam	Approved Investigational	SMC3	9126	downregulated	Piroxicam results in decreased expression of SMC3 mRNA	10q25.2	A23661
Piroxicam	Approved Investigational	SMS	6611	downregulated	Piroxicam results in decreased expression of SMS mRNA	Xp22.11	A21015
Piroxicam	Approved Investigational	SNRNP40	9410	downregulated	Piroxicam results in decreased expression of SNRNP40 mRNA	1p35.2	A23661

Displaying entries 59476 - 59500 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability